APA

Hadzijusufovic E., Albrecht-Schgoer K., Huber K., Hoermann G., Grebien F., Eisenwort G., Schgoer W., Herndlhofer S., Kaun C., Theurl M., Sperr W. R., Rix U., Sadovnik I., Jilma B., Schernthaner G. H., Wojta J., Wolf D., Superti-Furga G., Kirchmair R. & Valent P. (20171205). Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site. : Leukemia.

Chicago

Hadzijusufovic E, Albrecht-Schgoer K, Huber K, Hoermann G, Grebien F, Eisenwort G, Schgoer W, Herndlhofer S, Kaun C, Theurl M, Sperr W R, Rix U, Sadovnik I, Jilma B, Schernthaner G H, Wojta J, Wolf D, Superti-Furga G, Kirchmair R and Valent P. 20171205. Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site. : Leukemia.

Harvard

Hadzijusufovic E., Albrecht-Schgoer K., Huber K., Hoermann G., Grebien F., Eisenwort G., Schgoer W., Herndlhofer S., Kaun C., Theurl M., Sperr W. R., Rix U., Sadovnik I., Jilma B., Schernthaner G. H., Wojta J., Wolf D., Superti-Furga G., Kirchmair R. and Valent P. (20171205). Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site. : Leukemia.

MLA

Hadzijusufovic E, Albrecht-Schgoer K, Huber K, Hoermann G, Grebien F, Eisenwort G, Schgoer W, Herndlhofer S, Kaun C, Theurl M, Sperr W R, Rix U, Sadovnik I, Jilma B, Schernthaner G H, Wojta J, Wolf D, Superti-Furga G, Kirchmair R and Valent P. Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site. : Leukemia. 20171205.